Literature DB >> 29112647

Intrauterine Device Use and Cervical Cancer Risk: A Systematic Review and Meta-analysis.

Victoria K Cortessis1, Malcolm Barrett, Niquelle Brown Wade, Temuulen Enebish, Judith L Perrigo, Jessica Tobin, Charlie Zhong, Jennifer Zink, Vanessa Isiaka, Laila I Muderspach, Melissa Natavio, Roberta McKean-Cowdin.   

Abstract

OBJECTIVE: To estimate the association between use of an intrauterine device (IUD) and risk of cervical cancer by subjecting existing data to critical review, quantitative synthesis, and interpretation. DATA SOURCES: We searched PubMed, Web of Science, ClinicalTrials.gov, and catalogs of scientific meetings and abstracts, theses, and dissertations queried from inception through July 2016. METHODS OF STUDY SELECTION: Examination of abstracts from 225 reports identified 34 studies with individual-level measures of use of an IUD and incident cervical cancer. By critically assessing the full text of these reports, independent reviewers identified 17 studies conducted without recognized sources of systematic error, of which 16 could be harmonized for meta-analysis. TABULATION, INTEGRATION, AND
RESULTS: Point and interval estimates of the association between use of an IUD and incident cervical cancer were extracted from original reports into a structured database along with key features of study design and implementation. A random-effects meta-analysis was implemented to quantitatively synthesize extracted estimates and assess likely influence of publication bias, residual confounding, heterogeneity of true effect size, and human papillomavirus prevalence and cervical cancer incidence in source populations. Women who used an IUD experienced less cervical cancer (summary odds ratio 0.64, 95% CI 0.53-0.77). Neither confounding by recognized risk factors nor publication bias seems a plausible explanation for the apparent protective effect, which may be stronger in populations with higher cervical cancer incidence.
CONCLUSION: Invasive cervical cancer may be approximately one third less frequent in women who have used an IUD. This possible noncontraceptive benefit could be most beneficial in populations with severely limited access to screening and concomitantly high cervical cancer incidence.

Entities:  

Mesh:

Year:  2017        PMID: 29112647     DOI: 10.1097/AOG.0000000000002307

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  Recent intrauterine device use and the risk of precancerous cervical lesions and cervical cancer.

Authors:  Sarah Averbach; Michael J Silverberg; Wendy Leyden; Karen Smith-McCune; Tina Raine-Bennett; George F Sawaya
Journal:  Contraception       Date:  2018-04-17       Impact factor: 3.375

Review 2.  Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use.

Authors:  Karen Christelle; Mohd N Norhayati; Sharifah Halimah Jaafar
Journal:  Cochrane Database Syst Rev       Date:  2022-08-26

3.  Relative Risk of Cervical Neoplasms Among Copper and Levonorgestrel-Releasing Intrauterine System Users.

Authors:  Matthew E Spotnitz; Karthik Natarajan; Patrick B Ryan; Carolyn L Westhoff
Journal:  Obstet Gynecol       Date:  2020-02       Impact factor: 7.623

4.  Cervical Squamous Intraepithelial Lesions Are Associated with Differences in the Vaginal Microbiota of Mexican Women.

Authors:  M E Nieves-Ramírez; O Partida-Rodríguez; P Moran; A Serrano-Vázquez; H Pérez-Juárez; M E Pérez-Rodríguez; M C Arrieta; C Ximénez-García; B B Finlay
Journal:  Microbiol Spectr       Date:  2021-10-13

5.  Optimization of Cervical Cancer Screening: A Stacking-Integrated Machine Learning Algorithm Based on Demographic, Behavioral, and Clinical Factors.

Authors:  Lin Sun; Lingping Yang; Xiyao Liu; Lan Tang; Qi Zeng; Yuwen Gao; Qian Chen; Zhaohai Liu; Bin Peng
Journal:  Front Oncol       Date:  2022-02-15       Impact factor: 6.244

6.  Elastic Net-Based Identification of a Multigene Combination Predicting the Survival of Patients with Cervical Cancer.

Authors:  Hua Wang; Shu-Wei Li; Wei Li; Hong-Bing Cai
Journal:  Med Sci Monit       Date:  2019-12-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.